Status:
UNKNOWN
Standard-PCNL vs Mini-PCNL vs Super-mini PCNL for the Treatment of ≥2 cm Renal Stone
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Collaborating Sponsors:
Military Medical Academy, Bulgaria
Massachusetts General Hospital
Conditions:
Stone, Kidney
Lithiasis Renal
Eligibility:
All Genders
14+ years
Brief Summary
Background: Standard-PCNL was considered as the first choice for ≥2 cm renal stones. Miniaturized technique Mini-PCNL has also been implicated in the past two decades. Recently, Super-mini PCNL (SMP) ...
Detailed Description
BACKGROUND AND RATIONALE Percutaneous nephrolithotomy (PCNL) is the first-choice for the treatment of renal stone ≥20 mm with high stone free rate (SFR). However, there are some sever complications su...
Eligibility Criteria
Inclusion
- Patient ≥14 years old
- Patient is a candidate for Standard-PCNL, Mini-PCNL or SMP treatment of a renal stone
Exclusion
- Patient \<14 years old
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT03771365
Start Date
January 1 2019
End Date
January 1 2022
Last Update
December 11 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.